SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-21-000099
Filing Date
2021-04-16
Accepted
2021-04-16 20:17:23
Documents
1
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161861862957404.html 4  
1 FORM 4 wf-form4_161861862957404.xml 4 3599
  Complete submission text file 0001479290-21-000099.txt   4930
Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE TN 37203 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address
Sjuts Dustin S (Reporting) CIK: 0001796224 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 21832806